Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:831  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 

  Article Access Statistics

Year : 2022 | Volume:  14 | Issue Number:  2 | Page:  69-74

ORIGINAL ARTICLE

A randomized controlled trial of combined ivermectin and zinc sulfate versus combined hydroxychloroquine, darunavir/ritonavir, and zinc sulfate among adult patients with asymptomatic or mild coronavirus-19 infection
Nimitvilai Sireethorn, Suputtamongkol Yupin, Poolvivatchaikarn Ussanee, Rassamekulthana Dechatorn, Rongkiettechakorn Nuttawut, Mungaomklang Anek, Assanasaen Susan, Wongsawat Ekkarat, Boonarkart Chompunuch, Sawaengdee Waritta

Number of times this article was viewed 1179
Number of times this article has been printed  from the site 40
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0

 

  Addresses 
  My Preferences 
 Back To Article


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice | Contact Us
2022 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008